非缺血性心肌病室速导管消融治疗进展  

Progress of catheter ablation in treating ventricular tachycardia caused by nonischemic cardiomyopathy

作　　者：蒋伟[1] 郑强荪 JIANG Wei;ZHENG Qiangsun(Department of Cardiology,the Second Affiliated Hospital of Xi'an Jiaotong University,Xi'an Shaanxi 710000,China)

机构地区：[1]西安交通大学第二附属医院心内科,陕西西安710000

出　　处：《实用心电学杂志》2022年第6期405-409,421,共6页Journal of Practical Electrocardiology

基　　金：陕西省自然科学基金资助项目(2021JM-291)。

摘　　要：非缺血性心肌病室速的治疗在临床上面临挑战,而其导管消融治疗的相关临床数据较为有限。本文从导管消融治疗非缺血性心肌病室速的临床效果、标测方法、未来展望三个方面对其进展进行综述。The treatment of ventricular tachycardia caused by nonischemic cardiomyopathy(NICM-VT)is challenging in clinical practice,however,the related clinical data of catheter ablation for NICM-VT are limited.This paper reviews the progress of catheter ablation for NICM-VT from three aspects:clinical efficacy,mapping strategy,and future prospect.

关 键 词：非缺血性心肌病 导管消融 室性心动过速 基质标测 

分 类 号：R541.71[医药卫生—心血管疾病]